Literature DB >> 11879143

Novel mutation in the TIMP3 gene causes Sorsby fundus dystrophy.

Samuel G Jacobson1, Artur V Cideciyan, Jean Bennett, Ronald M Kingsley, Val C Sheffield, Edwin M Stone.   

Abstract

OBJECTIVE: To determine the molecular basis of a retinopathy previously described as dominant macular subretinal neovascularization with peripheral retinal degeneration.
METHODS: The TIMP3 gene was analyzed in family members, and 4 mutation-positive patients were studied using psychophysics and electroretinography.
RESULTS: Cosegregating with disease in the family was a single base pair change in the TIMP3 gene, altering a conserved tyrosine to cysteine at amino acid position 172 (Y172C). There was psychophysical and electroretinographic evidence of rod dysfunction greater than cone dysfunction. Dark adaptometry showed abnormalities with regional retinal variation in degree.
CONCLUSIONS: The Y172C mutation in the TIMP3 gene is another cause of Sorsby fundus dystrophy. The expression of this form of the disease, as in other C-terminal TIMP3 mutations, is speculated to be secondary to mutant TIMP-3, causing a decreased turnover of the extracellular matrix. CLINICAL RELEVANCE: The molecular clarification of inherited retinal degeneration involving abnormal extracellular matrix turnover in and around Bruch's membrane should provide clues to the pathogenesis of not only these particular diseases but also forms of age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879143     DOI: 10.1001/archopht.120.3.376

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

Review 1.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

2.  A novel TIMP3 mutation associated with a retinitis pigmentosa-like phenotype.

Authors:  Meghan J DeBenedictis; Yosef Gindzin; Enrico Glaab; Bela Anand-Apte
Journal:  Ophthalmic Genet       Date:  2020-07-27       Impact factor: 1.803

3.  Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.

Authors:  Mohammed A Majid; Valerie A Smith; Andrew C Newby; Andrew D Dick
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

4.  Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2.

Authors:  Sharon Elliot; Paola Catanuto; William Stetler-Stevenson; Scott W Cousins
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

Review 5.  Sorsby fundus dystrophy: Insights from the past and looking to the future.

Authors:  Bela Anand-Apte; Jennifer R Chao; Ruchira Singh; Heidi Stöhr
Journal:  J Neurosci Res       Date:  2018-08-21       Impact factor: 4.164

Review 6.  The genetics of inherited macular dystrophies.

Authors:  M Michaelides; D M Hunt; A T Moore
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

7.  Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury.

Authors:  Tyler Menge; Yuhai Zhao; Jing Zhao; Kathryn Wataha; Michael Gerber; Jianhu Zhang; Phillip Letourneau; John Redell; Li Shen; Jing Wang; Zhalong Peng; Hasen Xue; Rosemary Kozar; Charles S Cox; Aarif Y Khakoo; John B Holcomb; Pramod K Dash; Shibani Pati
Journal:  Sci Transl Med       Date:  2012-11-21       Impact factor: 17.956

8.  A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration.

Authors:  A Warwick; J Gibson; R Sood; A Lotery
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

Review 9.  Genetic basis of inherited macular dystrophies and implications for stem cell therapy.

Authors:  Carla B Mellough; David H W Steel; Majlinda Lako
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

10.  Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy.

Authors:  Z Saihan; Z Li; J Rice; N A Rana; S Ramsden; P G Schlottmann; S A Jenkins; C Blyth; G C Black; N McKie; A R Webster
Journal:  Mol Vis       Date:  2009-06-15       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.